Preclinical News and Research

RSS
Researchers develop first non-human primate X-SCID models using genome editing techniques

Researchers develop first non-human primate X-SCID models using genome editing techniques

AAV-based gene therapy to treat liver disorders advances into human testing

AAV-based gene therapy to treat liver disorders advances into human testing

Two research studies on new molecules could potentially treat Alzheimer's disease

Two research studies on new molecules could potentially treat Alzheimer's disease

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

New computational tool can predict personal cancer driver genes to optimize treatment

New computational tool can predict personal cancer driver genes to optimize treatment

AXT makes magnetic particle imaging technology available to researchers in Australia

AXT makes magnetic particle imaging technology available to researchers in Australia

Researchers receive NIH grant to map molecular changes linked to physical movement

Researchers receive NIH grant to map molecular changes linked to physical movement

Overexpression of nerve growth factor drives gastric tumorigenesis in mice

Overexpression of nerve growth factor drives gastric tumorigenesis in mice

Researchers identify attractive drug candidate to target glioma tumors

Researchers identify attractive drug candidate to target glioma tumors

Small, simple-to-use microfluidic device could speed up adoption of new anti-cancer treatments

Small, simple-to-use microfluidic device could speed up adoption of new anti-cancer treatments

Over-the-counter antioxidant may promote reductions in alcohol use in marijuana-dependent teens

Over-the-counter antioxidant may promote reductions in alcohol use in marijuana-dependent teens

Controversial hormone could fight against recurring breast cancers

Controversial hormone could fight against recurring breast cancers

Researchers show how common bacterium in improperly cooked chicken triggers GBS

Researchers show how common bacterium in improperly cooked chicken triggers GBS

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

New model can simplify process of mixing perfect drug cocktails

New model can simplify process of mixing perfect drug cocktails

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

MUSC researchers harness cutting-edge technology to uncover new role for pericytes during stroke

MUSC researchers harness cutting-edge technology to uncover new role for pericytes during stroke

Hemophilia B patients produce near-normal levels of clotting factor IX after gene therapy, study shows

Hemophilia B patients produce near-normal levels of clotting factor IX after gene therapy, study shows

Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

Experts explore if DXA-derived measurements could predict fracture risk in diabetic patients

Experts explore if DXA-derived measurements could predict fracture risk in diabetic patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.